|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Du XL, Key CR, Osborne C, Mahnken JD and
Goodwin JS: Discrepancy between consensus recommendations and
actual community use of adjuvant chemotherapy in women with breast
cancer. Ann Intern Med. 138:90–97. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen YY, Li ZZ, Ye YY, Xu F, Niu RJ, Zhang
HC, Zhang YJ, Liu YB and Han BS: Knockdown of SALL4 inhibits the
proliferation and reverses the resistance of MCF-7/ADR cells to
doxorubicin hydrochloride. BMC Mol Biol. 17:62016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang H, Yu Y, Jiang Z, Cao WM, Wang Z, Dou
J, Zhao Y, Cui Y and Zhang H: Next-generation proteasome inhibitor
MLN9708 sensitizes breast cancer cells to doxorubicin-induced
apoptosis. Sci Rep. 6:264562016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen NT, Wu CY, Chung CY, Hwu Y, Cheng SH,
Mou CY and Lo LW: Probing the dynamics of doxorubicin-DNA
intercalation during the initial activation of apoptosis by
fluorescence lifetime imaging microscopy (FLIM). PLoS One.
7:e449472012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng Y, Lv X, Wang X, Wang B, Shao X,
Huang Y, Shi L, Chen Z, Huang J and Huang P: MiR-181b promotes
chemoresistance in breast cancer by regulating Bim expression.
Oncol Rep. 35:683–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chakravarty G, Mathur A, Mallade P,
Gerlach S, Willis J, Datta A, Srivastav S, Abdel-Mageed AB and
Mondal D: Nelfinavir targets multiple drug resistance mechanisms to
increase the efficacy of doxorubicin in MCF-7/Dox breast cancer
cells. Biochimie. 124:53–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: MicroRNA pathways in flies and
worms: Growth, death, fat, stress, and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tan YY, Xu XY, Wang JF, Zhang CW and Zhang
SC: MiR-654-5p attenuates breast cancer progression by targeting
EPSTI1. Am J Cancer Res. 6:522–532. 2016.PubMed/NCBI
|
|
12
|
Gu X, Xue JQ, Han SJ, Qian SY and Zhang
WH: Circulating microRNA-451 as a predictor of resistance to
neoadjuvant chemotherapy in breast cancer. Cancer Biomark.
16:395–403. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ye Z, Hao R, Cai Y, Wang X and Huang G:
Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by
targeting the BIM-Bax/Bak axis in breast cancer. Tumour Biol.
37:4509–4515. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou S, Huang Q, Zheng S, Lin K, You J and
Zhang X: miR-27a regulates the sensitivity of breast cancer cells
to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis. Tumour Biol.
37:6837–6845. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Tian X, Han R, Zhang X, Wang X,
Shen H, Xue L, Liu Y, Yan X, Shen J, et al: Downregulation of
miR-486-5p contributes to tumor progression and metastasis by
targeting protumorigenic ARHGAP5 in lung cancer. Oncogene.
33:1181–1189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prathapan A, Vineetha VP and Raghu KG:
Protective effect of Boerhaavia diffusa L. against mitochondrial
dysfunction in angiotensin II induced hypertrophy in H9c2
cardiomyoblast cells. PLoS One. 9:e962202014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duan W, Jin X, Li Q, Tashiro S, Onodera S
and Ikejima T: Silibinin induced autophagic and apoptotic cell
death in HT1080 cells through a reactive oxygen species pathway. J
Pharmacol Sci. 113:48–56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Radhika V, Onesime D, Ha JH and
Dhanasekaran N: Galpha13 stimulates cell migration through
cortactin-interacting protein Hax-1. J Biol Chem. 279:49406–49413.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zorov DB, Juhaszova M and Sollott SJ:
Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS
release. Physiol Rev. 94:909–950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao X, He W, Li J, Huang S, Wan X, Luo H
and Wu D: MiRNA-125b inhibits proliferation and migration by
targeting SphK1 in bladder cancer. Am J Transl Res. 7:2346–2354.
2015.PubMed/NCBI
|
|
22
|
Lee M, Kim EJ and Jeon MJ: MicroRNAs 125a
and 125b inhibit ovarian cancer cells through post-transcriptional
inactivation of EIF4EBP1. Oncotarget. 7:8726–8742. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin W, Nie Y, Zhang Z, Xie L and He X:
miR-193b acts as a doxorubicin sensitizer via the
caspase-3-dependent pathway in HCC chemotherapy. Oncol Rep.
34:368–3674. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lv L, An X, Li H and Ma L: Effect of
miR-155 knockdown on the reversal of doxorubicin resistance in
human lung cancer A549/dox cells. Oncol Lett. 11:1161–1166.
2016.PubMed/NCBI
|
|
25
|
Tang XY, Zheng W, Ding M, Guo KJ, Yuan F,
Feng H, Deng B, Sun W, Hou Y and Gao L: miR-125b acts as a tumor
suppressor in chondrosarcoma cells by the sensitization to
doxorubicin through direct targeting the ErbB2-regulated glucose
metabolism. Drug Des Devel Ther. 10:571–583. 2016.PubMed/NCBI
|
|
26
|
Clarke R, Leonessa F and Trock B:
Multidrug resistance/P-glycoprotein and breast cancer: Review and
meta-analysis. Semin Oncol. 32(6 Supp 7): S9–S15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Suzuki Y, Demoliere C, Kitamura D,
Takeshita H, Deuschle U and Watanabe T: HAX-1, a novel
intracellular protein, localized on mitochondria, directly
associates with HS1, a substrate of Src family tyrosine kinases. J
Immunol. 158:2736–2744. 1997.PubMed/NCBI
|
|
28
|
Trebinska A, Högstrand K, Grandien A,
Grzybowska EA and Fadeel B: Exploring the anti-apoptotic role of
HAX-1 versus BCL-XL in cytokine-dependent bone marrow-derived cells
from mice. FEBS Lett. 588:2921–2927. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Trebinska A, Rembiszewska A, Ciosek K,
Ptaszynski K, Rowinski S, Kupryjanczyk J, Siedlecki JA and
Grzybowska EA: HAX-1 overexpression, splicing and cellular
localization in tumors. BMC Cancer. 10:762010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Halestrap AP, Clarke SJ and Javadov SA:
Mitochondrial permeability transition pore opening during
myocardial reperfusion-a target for cardioprotection. Cardiovasc
Res. 61:372–385. 2004. View Article : Google Scholar : PubMed/NCBI
|
